

Speak Pharma presents the 3rd edition, taking place in Vienna, Austria, and online on November 10–11, 2026. Industry leaders will examine Contamination Control Strategy (CCS) from a cleaning-validation perspective, focusing on how residue control, equipment cleanability, and lifecycle cleaning validation directly support a robust CCS under Annex 1. The program includes practical approaches for linking cleaning validation limits to contamination-control decisions, integrating analytical and microbiological data into CCS assessments, and improving risk-based control measures in multi-product operations. Through real-world case studies and guided discussions, participants will gain clear, actionable insights to strengthen their cleaning-driven CCS programs. Secure your spot now by submitting a request.
Subject 1 – Strategy & Regulatory Alignment
· Case-Based Approach and Evaluation of Recent Warning Letters
· Evolution of Cleaning Validation under Annex 1
· Regulatory and industry expectations in practice
· Building a risk-based CCS framework
· CCS implementation in multi-product facilities
· Digital tools for CCS monitoring and data integrity
· Linking cleaning validation to CCS risk matrices
Subject 2 – Implementation & Continuous Improvement
· Best practices in cleaning validation lifecycle
· Sampling and analytical methods
· Integrating environmental and microbiological controls into CCS
· Human factors and operator behaviour in contamination control
· Audit-ready documentation and CAPA integration
· Future direction of cleaning validation under Annex 1
Who Should Join
Professionals overseeing the full lifecycle of cleaning validation programs—from development through implementation and ongoing maintenance—across pharmaceuticals, biotechnology, vaccines, and sterile manufacturing, including integration within a site-wide Contamination Control Strategy (CCS).
Experts in quality assurance and control (QA/QC), microbiology, chemistry, analytical development laboratories, regulatory affairs, compliance, validation, and internal/external audit, responsible for ensuring regulatory alignment (including Annex 1), contamination control, and product quality.
Leaders and technical specialists from Manufacturing Science & Technology, process and formulation development, CMC, technology transfer, external supply, CMO/CDMO management, and packaging, accountable for evaluating cleaning systems, equipment design, cleanability, and practical execution of cleaning validation and CCS elements.
Decision-makers and strategic leaders in operations, plant management, business and strategic development, licensing, commercialisation, and new product introduction, seeking a deeper understanding of the science behind cleaning and cleaning validation, including residue selection, risk assessment, and their impact on CCS robustness.
Professionals involved in environmental monitoring, microbiological oversight, industrial hygiene, occupational and corporate toxicology, drug safety evaluation, and HSE/EHS, contributing critical data and risk-based insight to contamination control and CCS decision-making.
Engineering, production, sterilisation, process monitoring and control, and continuous processing personnel responsible for facility design, equipment configuration, process flow, and operational controls that enable effective contamination control and validated cleaning processes.








This site uses cookies. Find out more about cookies and how you can refuse them.
New membership are not allowed.